PP
MBII

Paloma Partners’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Paloma Partners’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-15,203
Closed -$19K – 2408
2020
Q3 		$19K Buy
+15,203
New +$18.5K ﹤0.01% 2005
2019
Q2 		– Sell
-10,494
Closed -$16K – 2306
2019
Q1 		$16K Sell
10,494
-39,006
-79% -$59.5K ﹤0.01% 1644
2018
Q4 		$73K Buy
+49,500
New +$75.8K ﹤0.01% 1138
2015
Q3 		– Sell
-21,450
Closed -$42K – 2034
2015
Q2 		$42K Buy
+21,450
New +$60.8K ﹤0.01% 1738

Other funds holding MBII

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Paloma Partners's MBII Position: Q4 2020 in Review

Paloma Partners sold out of Marrone Bio Innovations, Inc. (MBII) in Q4 2020, closing a stake of 15,203 shares — an estimated $19K sold.

Paloma Partners first reported a position in MBII in Q2 2015 and held it in 4 quarters. The position peaked at $73K in Q4 2018. 62 funds tracked by Wall St. Rank hold MBII as of Q4 2020.

  • Paloma Partners reported no remaining Marrone Bio Innovations, Inc. position as of Q4 2020 after selling out during the quarter.
  • Paloma Partners sold 15,203 Marrone Bio Innovations, Inc. shares in Q4 2020, an estimated $19K.
  • Paloma Partners first reported a position in Marrone Bio Innovations, Inc. in Q2 2015 and held it in 4 quarters.
  • Paloma Partners's Marrone Bio Innovations, Inc. position peaked at $73K in Q4 2018.
  • 62 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q4 2020.

Based on Paloma Partners's 13F filing for Q4 2020, filed 16 Feb 2021.